Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M.

Nature. 1996 Aug 22;382(6593):722-5.

PMID:
8751444
2.

Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.

Balotta C, Bagnarelli P, Violin M, Ridolfo AL, Zhou D, Berlusconi A, Corvasce S, Corbellino M, Clementi M, Clerici M, Moroni M, Galli M.

AIDS. 1997 Aug;11(10):F67-71.

PMID:
9256936
3.

Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele.

Furci L, Scarlatti G, Burastero S, Tambussi G, Colognesi C, Quillent C, Longhi R, Loverro P, Borgonovo B, Gaffi D, Carrow E, Malnati M, Lusso P, Siccardi AG, Lazzarin A, Beretta A.

J Exp Med. 1997 Aug 4;186(3):455-60.

4.

[Frequency of the mutated allele of CCR-5 receptor in HIV-1 positive and negative individuals in the Province of Chaco].

Motta P, Cibulsky L, Iliovich E, Habegger de Sorrentino A.

Medicina (B Aires). 2000;60(4):431-4. Spanish.

PMID:
11188946
5.

Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ.

Science. 1996 Sep 27;273(5283):1856-62. Erratum in: Science 1996 Nov 15;274(5290):1069.

PMID:
8791590
6.

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR.

Cell. 1996 Aug 9;86(3):367-77.

7.
8.

Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ.

Science. 1997 Aug 15;277(5328):959-65.

9.

Novel alleles of the chemokine-receptor gene CCR5.

Carrington M, Kissner T, Gerrard B, Ivanov S, O'Brien SJ, Dean M.

Am J Hum Genet. 1997 Dec;61(6):1261-7.

10.

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, Koup RA.

Nat Med. 1996 Nov;2(11):1240-3.

PMID:
8898752
11.

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, Sheppard HW.

Nat Med. 1997 Mar;3(3):338-40.

PMID:
9055864
12.

Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.

Reiche EM, Ehara Watanabe MA, Bonametti AM, Morimoto HK, Akira Morimoto A, Wiechmann SL, Matsuo T, Carvalho De Oliveira J, Vissoci Reiche F.

Int J Mol Med. 2008 Nov;22(5):669-75.

PMID:
18949389
13.

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.

Eugen-Olsen J, Iversen AK, Garred P, Koppelhus U, Pedersen C, Benfield TL, Sorensen AM, Katzenstein T, Dickmeiss E, Gerstoft J, Skinhøj P, Svejgaard A, Nielsen JO, Hofmann B.

AIDS. 1997 Mar;11(3):305-10.

PMID:
9147421
14.

Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.

Salem AH, Batzer MA.

Mutat Res. 2007 Mar 1;616(1-2):175-80. Epub 2006 Dec 12.

PMID:
17166523
15.

Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort.

Eugen-Olsen J, Iversen AK, Benfield TL, Koppelhus U, Garred P.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):110-6.

PMID:
9637575
16.

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

Meyer L, Magierowska M, Hubert JB, Rouzioux C, Deveau C, Sanson F, Debre P, Delfraissy JF, Theodorou I.

AIDS. 1997 Sep;11(11):F73-8.

PMID:
9302436
17.

[Comparison CCR5de132 mutation in the CCR5 gene frequencies in Russians, Tuvinians, and in different groups of HIV-infected individuals].

Apriatin SA, Rakhmanaliev ER, Nikolaeva IA, Ruban SV, Vazykhova FG, Klimov EA, Sulimova GE, Sidorovich IG.

Genetika. 2005 Nov;41(11):1559-62. Russian.

PMID:
16358723
18.

Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.

Kim A, Pettoello-Mantovani M, Goldstein H.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):145-9.

PMID:
9768623
19.

Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity.

Rucker J, Samson M, Doranz BJ, Libert F, Berson JF, Yi Y, Smyth RJ, Collman RG, Broder CC, Vassart G, Doms RW, Parmentier M.

Cell. 1996 Nov 1;87(3):437-46.

20.

Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.

Simmons G, Wilkinson D, Reeves JD, Dittmar MT, Beddows S, Weber J, Carnegie G, Desselberger U, Gray PW, Weiss RA, Clapham PR.

J Virol. 1996 Dec;70(12):8355-60.

Supplemental Content

Support Center